Fundz
Funding, M&A and exec moves matched to your market, guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Pharma Capital acquires Servier Morocco

PRIVATEAug 19, 2026about 14 hours ago

Acquiring Company

Pharma Capital

Acquired Company

Servier Morocco

Fort LauderdaleMoroccoManufacturingBiotechnologyBiotechnologyHealth CarePharmaceutical

Description

Pharma Capital has successfully acquired Servier Morocco. This acquisition will enhance Pharma Capital's position in the pharmaceutical market. The deal aims to leverage Servier Morocco's expertise in medical innovation. Stakeholders anticipate positive developments in patient care services.

Company Information

Company

Pharma Capital

Location

Fort Lauderdale, Florida, United States

About

Pharma Capital is a prominent player in the pharmaceutical sector. They focus on enhancing healthcare solutions through innovative products. The company aims to expand its market presence and improve patient care services. Their strategic initiatives often involve acquisitions and partnerships.

Don't miss Pharma Capital's next move

Get an email the moment Pharma Capital makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Pharma Capital's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Servier Morocco?

Servier Morocco was acquired by Pharma Capital, based in Fort Lauderdale. The deal was reported on August 19, 2026. Pharma Capital is a prominent player in the pharmaceutical sector. They focus on enhancing healthcare solutions through innovative products. Pharma Capital is privately held and operates in Manufacturing.

When did Pharma Capital acquire Servier Morocco?

Pharma Capital's acquisition of Servier Morocco was reported on August 19, 2026. Pharma Capital has successfully acquired Servier Morocco. This acquisition will enhance Pharma Capital's position in the pharmaceutical market. The deal aims to leverage Servier Morocco's expertise in medical innovation. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Servier Morocco do?

Servier Morocco is a subsidiary of Servier, an international pharmaceutical company. They are dedicated to research and development in the field of cardiology and diabetes treatments. The company emphasizes innovation and accessibility of medicines. It is privately held, operating in Biotechnology, and is based in Morocco.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.